Month: May 2021

VANCOUVER, British Columbia, May 20, 2021 (GLOBE NEWSWIRE) — Gold Standard Ventures Corp. (NYSE AMERICAN: GSV) (TSX: GSV) (“Gold Standard” or the “Company”) today announced plans for the 2021 exploration and development program on its vast land package in Nevada’s Carlin Trend. The program includes approximately 7,880 meters of reverse-circulation (“RC”) and core drilling over 46 holes. Drilling is anticipated to start in May 2021. (https://goldstandardv.com/site/assets/files/4499/2021_exploration_and_development_program.pdf) Exploration Focus Areas:Pinion SB Zone: 7 RC drill holes (approximately 2,350 meters) to further develop oxide mineralization at the SB Zone target. Previously released intercepts at SB Zone include: PR20-26 (77.7m of 2.24 g Au/t), PR20-30 (50.3m of 1.04 g Au/t), PC20-22 (61.1m of 1.07 g Au/t) (see November...

— New clinical data accepted for oral and e-Poster presentation at AACE — — e-ECE clinical data previously presented at Endocrine Society’s 2021 annual meeting — NEEDHAM, Mass., May 20, 2021 (GLOBE NEWSWIRE) — Chiasma, Inc. (NASDAQ: CHMA), (“Chiasma” or the “Company”), a commercial-stage biopharmaceutical company utilizing its delivery platform technology to develop and commercialize oral therapies to improve the lives of patients with rare diseases currently treated with burdensome and painful injections, today announced that it will virtually present encore data from its MPOWERED™ Phase 3 clinical trial at the 23rd European Congress of Endocrinology (e-ECE) (May 22-26, 2021) and new data from the MPOWERED trial at the 30th Annual American Association of Clinical Endocrinology (AACE) Meeting (May 26-29,...

MONTREAL, May 20, 2021 (GLOBE NEWSWIRE) — Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that it has paid off $250,000 in variable rate convertible debt and is planning to soon eliminate the two similar items remaining on the books of the Company. The Company’s application for uplisting to the OTCQB had been declined due to outstanding variable rate loans which were on the Company’s financial statements at the time of the application. The Company can re-apply in October 2021. Sunshine Biopharma’s CFO, Camille Sebaaly stated, “We are in the process of getting rid of these loans to minimize dilution. Protecting the shareholders against harmful dilution is of utmost importance to the management of Sunshine...

MOUNTAIN VIEW, Calif., May 20, 2021 (GLOBE NEWSWIRE) — NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy, today announced it will report financial results for the first quarter of 2021 before market open on Thursday, June 3, 2021. The company’s management will webcast a corresponding conference call beginning at 5:00 a.m. Pacific Time /8:00 a.m. Eastern Time. Investors interested in listening to the conference call may do so by dialing (844) 955-2173 for domestic callers or (914) 987-7949 for international callers, using conference ID: 1485513. Live audio of the webcast will be available on the “Investors” section of the company’s website at: https://investors.neuropace.com. The webcast will be archived and available for replay for at least...

Dr. Doebele, Rain co-founder, will continue to serve as chief scientific officer NEWARK, Calif., May 20, 2021 (GLOBE NEWSWIRE) — Rain Therapeutics Inc. (“Rain”), a clinical-stage company developing precision oncology therapeutics, today announced the appointment of Rain co-founder Robert Doebele, M.D., Ph.D. as president and chief scientific officer (“CSO”). As president, Dr. Doebele will play a critical role in shaping the company’s corporate strategy and operations and will continue to provide his precision oncology expertise to advance Rain’s clinical pipeline and lead the company’s research and development efforts as CSO. “It has been an honor and a joy to work closely with Bob since we founded Rain together, and I am delighted to recognize him as our new president,” said Avanish Vellanki, co-founder, chairman and chief executive...

PRINCETON, N.J., May 20, 2021 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that William Feehery, Chief Executive Officer, and Andrew Schemick, Chief Financial Officer, will participate in the following virtual investor conferences:William Blair’s 41st Annual Growth Stock ConferenceFireside Chat on Tuesday, June 1st at 11:40 a.m. ETJefferies Virtual Healthcare ConferenceFireside Chat on Friday, June 4th at 10:00 a.m. ETLive webcasts will be available on Certara’s investor relations website at https://ir.certara.com and will be available for replay for 90 days thereafter. About CertaraCertara accelerates medicines using biosimulation software and technology to transform traditional drug discovery and development. Its clients include more than 1,650 global biopharmaceutical...

WINNIPEG, Manitoba, May 20, 2021 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms, will announce its first quarter 2021 financial results after market close on Thursday, May 27, 2021. Kane Biotech management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments in the period. First Quarter 2021 Results Conference Call Details:Date:   Thursday May 27, 2021Time:   4:30 p.m. ETLive Call:    1-877-268-9044 (Canada and the United States)    1-706-679-2995 (International)     Replay:    1-404-537-3406Conference ID:   9992154The call will also be broadcast...

SEMINOLE, Fla., May 20, 2021 (GLOBE NEWSWIRE) —  Superior Group of Companies, Inc.® (NASDAQ: SGC) today announced that Michael Benstock, Chief Executive Officer, Andy Demott, Chief Operating Officer, Chief Financial Officer and Treasurer, and members of the senior executive division leadership, will participate in the Barrington Research Virtual Spring Investment Conference on May 27, 2021. Management will host virtual one-on-one and small group meetings throughout the day. About Superior Group of Companies, Inc. (SGC): Superior Group of Companies™ formerly Superior Uniform Group, established in 1920, is a combination of companies that help our customers unlock the power of their brands by creating extraordinary brand engagement experiences for their employees and customers. We provide customized support for each of our divisions...